156 reports of this reaction
1.0% of all AMPHETAMINE reports
#19 most reported adverse reaction
INTENTIONAL PRODUCT MISUSE is the #19 most commonly reported adverse reaction for AMPHETAMINE, manufactured by Amneal Pharmaceuticals NY LLC. There are 156 FDA adverse event reports linking AMPHETAMINE to INTENTIONAL PRODUCT MISUSE. This represents approximately 1.0% of all 14,926 adverse event reports for this drug.
Patients taking AMPHETAMINE who experience intentional product misuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL PRODUCT MISUSE is a less commonly reported adverse event for AMPHETAMINE, but still significant enough to appear in the safety profile.
In addition to intentional product misuse, the following adverse reactions have been reported for AMPHETAMINE:
The following drugs have also been linked to intentional product misuse in FDA adverse event reports:
INTENTIONAL PRODUCT MISUSE has been reported as an adverse event in 156 FDA reports for AMPHETAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL PRODUCT MISUSE accounts for approximately 1.0% of all adverse event reports for AMPHETAMINE, making it a notable side effect.
If you experience intentional product misuse while taking AMPHETAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.